{"title":"关节内注射皮质类固醇联合物理治疗与单独注射皮质类固醇治疗早期肩周炎的比较:一项随机临床试验","authors":"Md. Nasiruddin Md. Nasiruddin, Mushfique Manjur, Md. Sazzadul Haque, Md. Jafrul Islam, Md. Alamgir Hossain","doi":"10.36347/sjams.2023.v11i10.009","DOIUrl":null,"url":null,"abstract":"Introduction: Frozen shoulder (FS) is the most prevalent cause of shoulder pain and impairment, affecting 2-4% of all adults. As an appropriate strategy of treatment for FS, supportive physiotherapy treatment (PT) and exercises within the limits of pain has been recommended. Objective: To compare between intra-articular corticosteroid injection with physiotherapy and corticosteroid injection alone in the management of early-stage frozen shoulder. Methods: This prospective randomized clinical trial study was done among 23 patients with symptoms of early-stage (stage I or II) FS in the Department of Orthopedics, Monno Medical College Hospital from July to December 2022. Two groups were formed out of all the patients. While the other group (non-PT) did not receive any additional physiotherapy treatment, one group did. A follow-up was planned for weeks 6, 12, and 26. Results: Patients who had symptoms for ≥6 months was significantly higher in PT group (81.8%) in comparison to non-PT group (p<0.05). Patients who took physiotherapy treatment was significantly higher in PT group (72.7%) in comparison to non-PT group (p<0.05). The median total SPADI scores in the PT group at baseline, which were 82 (IQR: 35-86) and in the non-PT group, which were 80 (IQR: 65-87), showed the significant pain and limitations of frozen shoulder (FS) in its early stages. Both therapy groups significantly improved at the primary endpoint of 6 weeks for SPADI scores (p<0.05). At 6 weeks compared to baseline, passive ROM increased significantly (p<0.05). Each of the three ROM orientations showed significant changes in favor of the PT group after 12 weeks (p<0.05). At 6 weeks after baseline, both pain scores and Rand-36 physical component scale scores significantly increased (p<0.05). Conclusion: In the first 12 weeks of the early stage of frozen shoulder, physiotherapy in addition to corticosteroid injection improves range of motion (ROM) and functional mobility limitations compared ............","PeriodicalId":471520,"journal":{"name":"Scholars journal of applied medical sciences","volume":"45 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparison between Intra-Articular Corticosteroid Injection with Physiotherapy and Corticosteroid Injection Alone in Management of Early Stage Frozen Shoulders: A Randomized Clinical Trial\",\"authors\":\"Md. Nasiruddin Md. Nasiruddin, Mushfique Manjur, Md. Sazzadul Haque, Md. Jafrul Islam, Md. Alamgir Hossain\",\"doi\":\"10.36347/sjams.2023.v11i10.009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Frozen shoulder (FS) is the most prevalent cause of shoulder pain and impairment, affecting 2-4% of all adults. As an appropriate strategy of treatment for FS, supportive physiotherapy treatment (PT) and exercises within the limits of pain has been recommended. Objective: To compare between intra-articular corticosteroid injection with physiotherapy and corticosteroid injection alone in the management of early-stage frozen shoulder. Methods: This prospective randomized clinical trial study was done among 23 patients with symptoms of early-stage (stage I or II) FS in the Department of Orthopedics, Monno Medical College Hospital from July to December 2022. Two groups were formed out of all the patients. While the other group (non-PT) did not receive any additional physiotherapy treatment, one group did. A follow-up was planned for weeks 6, 12, and 26. Results: Patients who had symptoms for ≥6 months was significantly higher in PT group (81.8%) in comparison to non-PT group (p<0.05). Patients who took physiotherapy treatment was significantly higher in PT group (72.7%) in comparison to non-PT group (p<0.05). The median total SPADI scores in the PT group at baseline, which were 82 (IQR: 35-86) and in the non-PT group, which were 80 (IQR: 65-87), showed the significant pain and limitations of frozen shoulder (FS) in its early stages. Both therapy groups significantly improved at the primary endpoint of 6 weeks for SPADI scores (p<0.05). At 6 weeks compared to baseline, passive ROM increased significantly (p<0.05). Each of the three ROM orientations showed significant changes in favor of the PT group after 12 weeks (p<0.05). At 6 weeks after baseline, both pain scores and Rand-36 physical component scale scores significantly increased (p<0.05). Conclusion: In the first 12 weeks of the early stage of frozen shoulder, physiotherapy in addition to corticosteroid injection improves range of motion (ROM) and functional mobility limitations compared ............\",\"PeriodicalId\":471520,\"journal\":{\"name\":\"Scholars journal of applied medical sciences\",\"volume\":\"45 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Scholars journal of applied medical sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36347/sjams.2023.v11i10.009\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scholars journal of applied medical sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36347/sjams.2023.v11i10.009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Comparison between Intra-Articular Corticosteroid Injection with Physiotherapy and Corticosteroid Injection Alone in Management of Early Stage Frozen Shoulders: A Randomized Clinical Trial
Introduction: Frozen shoulder (FS) is the most prevalent cause of shoulder pain and impairment, affecting 2-4% of all adults. As an appropriate strategy of treatment for FS, supportive physiotherapy treatment (PT) and exercises within the limits of pain has been recommended. Objective: To compare between intra-articular corticosteroid injection with physiotherapy and corticosteroid injection alone in the management of early-stage frozen shoulder. Methods: This prospective randomized clinical trial study was done among 23 patients with symptoms of early-stage (stage I or II) FS in the Department of Orthopedics, Monno Medical College Hospital from July to December 2022. Two groups were formed out of all the patients. While the other group (non-PT) did not receive any additional physiotherapy treatment, one group did. A follow-up was planned for weeks 6, 12, and 26. Results: Patients who had symptoms for ≥6 months was significantly higher in PT group (81.8%) in comparison to non-PT group (p<0.05). Patients who took physiotherapy treatment was significantly higher in PT group (72.7%) in comparison to non-PT group (p<0.05). The median total SPADI scores in the PT group at baseline, which were 82 (IQR: 35-86) and in the non-PT group, which were 80 (IQR: 65-87), showed the significant pain and limitations of frozen shoulder (FS) in its early stages. Both therapy groups significantly improved at the primary endpoint of 6 weeks for SPADI scores (p<0.05). At 6 weeks compared to baseline, passive ROM increased significantly (p<0.05). Each of the three ROM orientations showed significant changes in favor of the PT group after 12 weeks (p<0.05). At 6 weeks after baseline, both pain scores and Rand-36 physical component scale scores significantly increased (p<0.05). Conclusion: In the first 12 weeks of the early stage of frozen shoulder, physiotherapy in addition to corticosteroid injection improves range of motion (ROM) and functional mobility limitations compared ............